1. Global Safety Assessment; AstraZeneca R&D; Södertälje Sweden
2. Medical Products Agency; Uppsala Sweden
3. Neuroscience, Innovative Medicines CNS/Pain; AstraZeneca R&D; Södertälje Sweden
4. The National Board of Health and Welfare; Stockholm Sweden
5. Pharmaceutical Development, Medicines Evaluation CNS/Pain; AstraZeneca R&D; Södertälje Sweden
6. SP Process Development; Södertälje Sweden
7. Cancer Center Karolinska; Karolinska Institute and Hospital; Stockholm Sweden
8. Clinical Sciences, Neuroscience Therapeutic Area; AstraZeneca R&D; Södertälje Sweden
9. Pain Clinic; Karolinska Hospital Huddinge and CLINTEC Karolinska Institute; Stockholm Sweden